Topics
Oligodendroglioma | Treatment | Clinical trials | Nivolumab
Home > Publications > Topics > Oligodendroglioma > Treatment > Clinical trials > Nivolumab
Astrocytoma, anaplastic; Astrocytoma, NOS; Glioblastoma, NOS; Oligodendroglioma, anaplastic; Oligodendroglioma, NOS
Nguyen MK, Jelinek M, Singh A, Isett B, Myers ES, Mullett SJ,
Eisele Y, Beumer J, Parise R, Urban J, Rose A, Sellitto L, Singh
K, Doerfler R, Dadey RE, Kim C, Rhee JC, Davar D, Villaruz LC,
Burgess M, Drappatz J, Mantica M, Goodman AE, Wang H, Singhi AD,
Luke JJ, Zandberg DP, Bao R.
Clinical
and translational study of ivosidenib plus nivolumab in advanced
solid tumors harboring IDH1 mutations.
medRxiv
[Preprint]. 2025 Jul 21:2025.07.19.25331848. doi:
10.1101/2025.07.19.25331848. PMID:
40778139. Interventional study. ˍ
ClinicalTrials.gov
ID: NCT04056910.